Nuvalent Inc vs ProShares Ultra Semiconductors — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while ProShares Ultra Semiconductors trades at $90.13. The key difference: Nuvalent Inc is trading nearer its 52-week high, ProShares Ultra Semiconductors nearer its low. Which is the better fit depends on your goals.
| NUVL | USD | |
|---|---|---|
Market Cap | $9.81B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $123.96 | $113.53 |
52-Week Low | $72.16 | $39.58 |
Enterprise Value | $8.52B | — |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Read more on USD →